Invention Grant
- Patent Title: Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy
-
Application No.: US15568007Application Date: 2016-04-22
-
Publication No.: US10822400B2Publication Date: 2020-11-03
- Inventor: Jocelyn Laporte , Belinda Cowling
- Applicant: UNIVERSITE DE STRASBOURG , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Applicant Address: FR Strasbourg FR Paris FR Paris
- Assignee: UNIVERSITE DE STRASBOURG,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Current Assignee: UNIVERSITE DE STRASBOURG,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Current Assignee Address: FR Strasbourg FR Paris FR Paris
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2f3210e5
- International Application: PCT/EP2016/059090 WO 20160422
- International Announcement: WO2016/170162 WO 20161027
- Main IPC: C07K16/18
- IPC: C07K16/18 ; C12N15/113 ; A61P21/00 ; A61K45/06
Abstract:
The present disclosure relates to an inhibitor of Dynamin 2 or composition comprising the same for use in the treatment of Duchenne's muscular dystrophy.
Public/Granted literature
- US20180142008A1 DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY Public/Granted day:2018-05-24
Information query
